How Drug Companies Keep Medicine Out of Reach – The Atlantic

The promise of delinking research and development from the actual manufacture of drugs, and why the pharmaceutical industry rejects an idea that could turn neglected diseases into profit.

Advertisements
By timmreardon

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s